LB Pharmaceuticals Inc Common Stock (LBRX) vs Pacira BioSciences, Inc. (PCRX)
A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and Pacira BioSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LBRX
LB Pharmaceuticals Inc Common Stock
$34.14HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
PCRX
Pacira BioSciences, Inc.
$24.70HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — LBRX vs PCRX
growth of $100 · dividends reinvested · last 1yLBRX +100.1% (+100.1%/yr)PCRX -7.3% (-7.3%/yr)LBRX compounded faster over this window
LBRX PCRX
LBRX vs PCRX: by the numbers
- •LBRX is the larger company ($979M vs $971M market cap).
- •PCRX is profitable (1.96% net margin) while LBRX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | LBRX | PCRX |
|---|---|---|
| P/E ratio | N/A | 70.30 |
| P/S ratio | N/A | 1.30 |
| P/B ratio | 2.95 | 1.45 |
| EV / EBITDA | N/A | 11.37 |
| FCF yield | N/A | 18.48% |
Profitability
| Metric | LBRX | PCRX |
|---|---|---|
| Gross margin | 0.00% | 79.21% |
| Operating margin | 0.00% | 2.47% |
| Net margin | 0.00% | 1.96% |
| ROE | -25.78% | 2.18% |
| ROIC | -28.14% | 1.35% |
Growth (annualized)
| Metric | LBRX | PCRX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.20% |
| EPS CAGR (5Y) | N/A | -45.77% |
| FCF CAGR (5Y) | N/A | 16.72% |
| Total return CAGR (5Y) | N/A | -12.27% |
Frequently asked
- Is LBRX or PCRX more profitable?
- PCRX runs the higher net margin — LBRX at 0.00% versus PCRX at 1.96%.
Go deeper
Dig into the metrics
Pacira BioSciences P/E ratioLB Pharmaceuticals Inc Common Stock ROEPacira BioSciences ROELB Pharmaceuticals Inc Common Stock operating marginPacira BioSciences operating marginLB Pharmaceuticals Inc Common Stock revenue growthPacira BioSciences revenue growthLB Pharmaceuticals Inc Common Stock free cash flowPacira BioSciences free cash flow
LB Pharmaceuticals Inc Common Stock & Pacira BioSciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.